# Pharmacy P25-P34 UAT Acceptance Evidence Review

**Review date:** 2026-08-29  
**Branch reviewed:** `feature/pharmacy-module`  
**Final decision:** **NOT UAT READY**

## Executive Summary

The earlier statement of 46 passing tests was not reproduced as complete acceptance evidence. The mandatory focused P30 service suite passed (`8 passed`, exit `0`), but it runs on SQLite in-memory fixtures and is therefore unit evidence, not PostgreSQL integration evidence. The complete discovered Pharmacy-focused backend selection failed, the full backend regression suite failed, PostgreSQL Alembic upgrade failed during the configured E2E setup, and the frontend type-check and production build failed. No deployment, branch merge, Lab development, reset, or destructive repository operation was performed by this review.

The reviewed branch contains uncommitted P30/P31-P34 changes and pre-existing Lab-related changes. They were preserved without modification. The presence of Lab files is a repository-state finding, not work performed by this review.

## Scope And Evidence Standard

P25 covers medicine/formulary/prescription master data; P26 supplier/procurement/GRN; P27 inventory/ledger; P28 dispensing; P29 billing linkage/RBAC; P30 returns; P31 damage/expiry/recall; P32 transfers; P33 cycle counts; P34 dashboards/audit.

A test is marked as successful only when this review observed a successful execution. SQLite fixtures, `AsyncMock`, model-construction assertions, and reduced-schema PostgreSQL constraint tests are identified separately and are not accepted as real full-application PostgreSQL workflow evidence.

## Commands Executed

| Working directory | Exact command | Result |
|---|---|---|
| `D:\Personal\HMS\HMS-tenant\backend` | `python -m pytest tests/test_p30_returns.py -v` with `DATABASE_URL=postgresql+asyncpg://hospital_user:hospital_pass@localhost:5433/hospital`, `SECRET_KEY=test-secret-key`, `REDIS_URL=redis://localhost:6379` | `8 passed, 51 warnings in 0.33s`; exit `0` |
| `D:\Personal\HMS\HMS-tenant\backend` | `python -m pytest -v` over the 27 listed Pharmacy files below with the same environment | Failed; exit `1` |
| `D:\Personal\HMS\HMS-tenant\backend` | `python -m pytest tests -q` with the same environment | `228 passed, 72 failed, 42 errors, 113 warnings in 87.29s`; exit `1` |
| `D:\Personal\HMS\HMS-tenant\backend` | `python -m alembic current` | `0080 (head)`; exit `0` |
| `D:\Personal\HMS\HMS-tenant\backend` | `python -m alembic heads` | `0080 (head)`; exit `0` |
| `D:\Personal\HMS\HMS-tenant\backend` | `python -m alembic upgrade head` | Failed at revision `0077`; exit `1` |
| `D:\Personal\HMS\HMS-tenant\backend` | `python -m alembic current` | `0080 (head)`; exit `0` |
| `D:\Personal\HMS\HMS-tenant\frontend` | `npm run type-check` | 7 TypeScript errors; exit `2` |
| `D:\Personal\HMS\HMS-tenant\frontend` | `npm run lint` | Passed cleanly; exit `0` |
| `D:\Personal\HMS\HMS-tenant\frontend` | `npm run test:unit` | `2` files / `5` tests passed; exit `0` |
| `D:\Personal\HMS\HMS-tenant\frontend` | `npm run build` | Failed during `tsc -b`; exit `1`; Vite did not run |
| `D:\Personal\HMS\HMS-tenant\frontend` | `npx playwright test e2e/pharmacy-prescription.spec.ts e2e/pharmacy-p28.spec.ts --project=chromium --workers=1` | First attempt: 0 tests because port `8000` already in use; exit `1` |
| `D:\Personal\HMS\HMS-tenant\frontend` | Same Playwright command with `E2E_MANAGED_BACKEND=false`, `E2E_ENVIRONMENT=E2E`, `E2E_ALLOW_DESTRUCTIVE_RESET=true`, real PostgreSQL URL | 0 browser tests: global setup failed during Alembic; exit `1` |

The real-stack Playwright configuration specifies Chromium, one worker, no local retries, and failure artifacts under `frontend/test-results/` with HTML report under `frontend/playwright-report/`. No test began, so no test-specific screenshot/video/trace artifact was generated in this review.

## Executed Pharmacy Test Files

The following 27 files were selected for the focused run. The run was not green; its P30 comprehensive failures are specified below. No phase is treated as passed merely because its test file was selected.

| Phase | Selected test files | Evidence classification |
|---|---|---|
| P25 | `test_generic_medicine_master_phase25.py`, `test_dosage_form_route_master_phase25.py`, `test_manufacturer_master_phase25.py`, `test_medicine_product_master_phase25.py`, `test_hospital_formulary_phase25.py`, `test_formulary_medicine_search_phase25.py`, `test_prescription_product_integration_phase25.py`, `test_prescription_quantity_controls_phase25.py`, `test_pharmacy_backend_api_phase25.py`, `test_pharmacy_permissions_phase25.py` | Mostly SQLite/unit and route/schema/permission dependency assertions. No executed green real-postgres API acceptance evidence identified. |
| P26 | `test_supplier_master_phase26.py`, `test_purchase_order_model_phase26.py`, `test_purchase_order_workflow_phase26.py`, `test_goods_receipt_workflow_phase26.py`, `test_grn_batch_expiry_phase26.py`, `test_procurement_api_contract_phase26.py` | Focused run not green. Full suite reports P26 failures including PO tests and supplier-master tests. |
| P27 | `test_inventory_phase27.py`, `test_inventory_service_phase27.py`, `test_stock_transaction_phase27.py` | Focused run not green. Full suite reports stock transaction failures. |
| P28 | `test_dispensing_model_phase28.py`, `test_pharmacy_validation_phase28.py`, `test_pharmacy_phase12.py` | `test_pharmacy_validation_phase28.py` uses SQLite in-memory; full suite reports `test_pharmacy_phase12.py` failed with `KeyError: 'tenant_id'`. The existing P28 Playwright spec did not start. |
| P29 | `test_p29_rbac_audit_phase29.py`, `test_pharmacy_billing_linkage_phase29.py` | Billing linkage is PostgreSQL but creates a reduced temporary schema and tests only linkage uniqueness; it is not full-stack billing acceptance. No phase-wide green result established in this review. |
| P30 | `test_p30_returns.py`, `test_p30_comprehensive_acceptance.py` | Service test passed on SQLite. Comprehensive test failed. |
| P31 | `test_p31_p34_comprehensive.py` | Model/mock-session construction only; no workflow, DB, API, RBAC, isolation, or E2E evidence. |
| P32 | `test_p31_p34_comprehensive.py` | Model/mock-session construction only; no transfer service, transaction, RBAC, isolation, or E2E evidence. |
| P33 | `test_p31_p34_comprehensive.py` | Model/mock-session construction only; no cycle-count workflow, transaction, RBAC, isolation, or E2E evidence. |
| P34 | `test_p31_p34_comprehensive.py` | Model/mock-session construction only; no dashboard/report API or browser evidence. |

### P30 Exact Successfully Executed Test Names

`backend/tests/test_p30_returns.py` was rerun and all eight tests passed:

1. `TestPatientReturnService::test_request_patient_return_success`
2. `TestPatientReturnService::test_patient_return_validate`
3. `TestPatientReturnService::test_patient_return_reject`
4. `TestSupplierReturnService::test_request_supplier_return_success`
5. `TestSupplierReturnService::test_supplier_return_approve`
6. `TestSupplierReturnService::test_supplier_return_full_lifecycle`
7. `TestPatientReturnIntegration::test_patient_return_stock_ledger_entry`
8. `TestReturnIdempotency::test_duplicate_return_request_rejected`

Unabridged pytest result summary: `======================= 8 passed, 51 warnings in 0.33s ========================`.

The 51 warnings are non-blocking for that isolated test result but include `pytest-asyncio` fixture-loop configuration/redefined-loop deprecations, Pydantic v2 deprecations (`class Config`, `min_items`, `from_orm`), and Python 3.13 deprecations for `datetime.utcnow()` in returns code/tests.

### P30 Comprehensive Collection And Result

`test_p30_comprehensive_acceptance.py` collected these eight tests:

- `TestP30PatientReturnIntegration::test_patient_return_workflow_with_real_db`
- `TestP30PatientReturnIntegration::test_patient_return_duplicate_prevention`
- `TestP30PatientReturnIntegration::test_patient_return_cross_tenant_isolation`
- `TestP30SupplierReturnIntegration::test_supplier_return_workflow_with_real_db`
- `TestP30SupplierReturnIntegration::test_supplier_return_quantity_validation`
- `TestP30AuditAndCompliance::test_return_audit_trail_creation`
- `TestP30StockLedgerReconciliation::test_accepted_return_creates_ledger_entry`
- `TestP30StockLedgerReconciliation::test_return_reversal_on_rejection`

Six tests failed because the fixture supplied an `async_generator` rather than an `AsyncSession` (`AttributeError: 'async_generator' object has no attribute 'add'` or `add_all`). The two ledger tests contain `pass` placeholders, so they provide no assertion of accepted-return ledger entries or rejection reversal. This test module is not acceptable PostgreSQL integration evidence.

### P31-P34 Exact Test Names Present

`test_p31_p34_comprehensive.py` contains the following model/mock-session assertions, not end-to-end acceptance tests:

- P31: `TestP31Quarantine::test_create_quarantine_for_expired_stock`, `test_approve_quarantine_for_disposal`; `TestP31ProductRecall::test_create_batch_level_recall`, `test_create_product_level_recall`.
- P32: `TestP32StockTransfer::test_create_stock_transfer_request`, `test_transfer_with_items`.
- P33: `TestP33StockCount::test_initiate_stock_count`, `test_count_with_variance_detection`.
- P34: `TestP34DashboardAlerts::test_create_low_stock_alert`, `test_acknowledge_alert`, `test_create_audit_trail_entry`.

No focused test execution result for these P31-P34 nodes can be claimed as passing because the 27-file focused suite exited `1`.

## P30 Full-Acceptance Assessment

| Required P30 evidence | Observed result |
|---|---|
| Patient and supplier returns, full/partial, duplicate request | SQLite unit-level coverage only; the dedicated 8 tests passed. Full/partial API/real DB acceptance not proven. |
| Damaged and expired stock | No successful P30 execution evidence. |
| Idempotency-key replay | One SQLite duplicate-return rejection test passed. No real DB key-replay evidence. |
| Eligible-dispense / batch-balance over-return prevention | P30 comprehensive test intended to cover this but failed before database work. No acceptance proof. |
| Batch/expiry linkage, stock balances, ledger, audit, billing refs | Not proven. Two purported ledger tests are placeholders. |
| Rollback, concurrent patient/supplier returns, double-return prevention, negative inventory, duplicate ledger prevention | No real PostgreSQL concurrent execution evidence. |

## RBAC And Tenant Isolation

Positive/negative acceptance evidence for every Pharmacy role and operation was not executed successfully. `test_pharmacy_permissions_phase25.py` verifies `require_permission` with a `FakeSession`, not authenticated API requests. P29 and P28 migrations declare role permission assignments, but migration declarations are not endpoint authorization evidence.

| Role / operation | Intended permission evidence in source | Successfully tested through backend API / browser in this review |
|---|---|---|
| Pharmacist: queue/dispense/returns/inventory | P28/P29 permission migrations | No |
| Hospital admin: Pharmacy master/procurement/dispense/billing | P25-P29 permission migrations | No |
| Doctor: must not dispense/adjust/transfer/return | No successful negative API test observed | No |
| Nurse/receptionist: restricted Pharmacy operations | No successful negative API test observed | No |
| Tenant admin approved permissions only | No successful role-operation API matrix observed | No |
| Super-admin platform rules | No successful Pharmacy-specific API test observed | No |
| Frontend hidden/disabled controls and backend independence | No browser test started; no paired UI/API authorization test observed | No |

The multi-tenant middleware implementation and previous non-Pharmacy tenant tests are not substituted for Pharmacy P25-P34 resource isolation. No successful two-tenant proof was executed for medicines, suppliers, POs, GRNs, batches, balances, prescriptions, dispensing, returns, transfers, counts, or ledger entries. No evidence verifies request body/path/query/header tenant overrides across Pharmacy endpoints. Cross-tenant response non-disclosure and all tenant-filtered database query paths remain unproven for this acceptance decision.

## Concurrency, Transactions, Inventory And Ledger

No real PostgreSQL concurrency test was successfully executed for simultaneous returns or dispensing. The only observed PostgreSQL-related Pharmacy test is `test_pharmacy_billing_linkage_phase29.py`, which creates a temporary reduced schema and proves a unique invoice-per-dispense constraint with two concurrent inserts. It does not execute the HMS application service/API or prove return, stock, ledger, rollback, or reconciliation behavior.

Source models declare constraints such as dispense idempotency uniqueness, non-negative item quantities, fulfillment bounds, and allocation uniqueness. These declarations do not replace real concurrency tests. This review does not establish `SELECT FOR UPDATE`, optimistic locking, transaction isolation, or constraint behavior for P30 returns, P31 write-offs, P32 transfers, or P33 counts under concurrent real application requests.

The requested reconciliation equation was not proven for any full workflow:

`opening + accepted GRN + valid patient returns + positive adjustments + incoming transfers - dispensing - supplier returns - write-offs - negative adjustments - outgoing transfers = closing`.

No evidence was successfully executed for immutable ledger enforcement, compensating reversals, orphan detection, transaction-to-ledger completeness, or batch-to-inventory reconciliation.

## Database Migration Evidence

The configured PostgreSQL connection was used, not SQLite.

- Revision before upgrade attempt: `0080 (head)`.
- Declared Alembic head: `0080 (head)`.
- `alembic upgrade head` nevertheless attempted tenant-schema upgrades and failed at migration `0077` with `asyncpg.exceptions.DuplicateTableError: relation "ix_lab_test_master_code" already exists` while issuing `CREATE INDEX ix_lab_test_master_code ON lab_test_master (code)`.
- Revision reported after the failed attempt: `0080 (head)`.

A clean PostgreSQL database upgrade, supported pre-Pharmacy upgrade, downgrade/re-upgrade, schema consistency, and Pharmacy tenant uniqueness/index verification were not run successfully. They therefore remain mandatory missing evidence. No downgrade was attempted because the current shared database is not an isolated acceptance database and the task prohibits destructive/unrelated changes.

## Frontend And Playwright Evidence

- Type-check: failed with seven errors in `frontend/src/features/doctor/LabResultsPage.tsx` (unused `useEffect`; missing `lab_result`, `verified_at`, `verified_by_user_id` on `LabOrder`; missing `uhid` on `Visit`). Blocking because the production build depends on TypeScript compilation.
- ESLint: passed, no warnings.
- Unit tests: 2 files and 5 tests passed. Zustand persist middleware repeatedly warned that storage was unavailable when updating `hospital-auth`; non-blocking unit-test warning, but not Pharmacy component coverage.
- Build: failed with the same seven TypeScript errors; Vite production packaging did not execute.
- Component tests: no separate component-test command or successful component-test evidence was found.
- Playwright: Pharmacy P25 prescription and P28 dispensing specs were selected for Chromium. The first run executed 0 tests due occupied port `8000`; the second executed 0 tests because global setup failed on the PostgreSQL migration error. No P26, P27, P29, P30, P31, P32, P33, P34 or relevant OPD/prescription browser regression workflow ran successfully.

## Traceability Matrix

| Phase | Requirement | Implementation surface identified | Database/migration identified | Unit/integration/E2E evidence result | Status / limitation |
|---|---|---|---|---|---|
| P25 | Master data, formulary, structured prescription | `app/api/v1/master_data.py`, `app/api/v1/pharmacy.py`, prescription normalization; frontend `e2e/pharmacy-prescription.spec.ts` | `0050`-`0057` | Tests selected; no phase-wide successful acceptance result. E2E did not start. | Not accepted |
| P26 | Supplier, PO, GRN, batch/expiry | `app/api/v1/pharmacy.py` procurement routes | `0058`-`0061` | Focused/full regression failures; no E2E. | Not accepted |
| P27 | Locations, batches, inventory, stock ledger, adjustments | `app/services/inventory_service.py`, pharmacy inventory routes | `0062`-`0066` | Focused/full regression failures; no reconciliation evidence. | Not accepted |
| P28 | Dispensing, FEFO, reservations, billing handoff | `app/services/pharmacy_dispensing.py`, pharmacy routes; `e2e/pharmacy-p28.spec.ts` | `0067`-`0073` | SQLite validation exists; one phase test failed in full suite; E2E did not start. | Not accepted |
| P29 | Billing linkage and permissions | pharmacy/billing services; P29 RBAC test files | `0074`-`0076` | Reduced-schema PostgreSQL linkage test exists; full workflow/RBAC E2E absent. | Not accepted |
| P30 | Patient/supplier returns | `app/api/v1/returns.py`, `app/services/returns_service.py` | `0080_p30_patient_supplier_returns.py` | SQLite 8/8 passed. Dedicated comprehensive PostgreSQL module failed and has placeholders. | Not accepted |
| P31 | Damaged/expired/recall stock | `app/models/tenant/p31_p34.py` | No successful migration evidence | Model/mock tests only. | Not accepted |
| P32 | Transfer/multi-location | `app/models/tenant/p31_p34.py` | No successful migration evidence | Model/mock tests only. | Not accepted |
| P33 | Cycle count/physical verification | `app/models/tenant/p31_p34.py` | No successful migration evidence | Model/mock tests only. | Not accepted |
| P34 | Dashboard/reports/audit | `app/models/tenant/p31_p34.py`, `app/services/stock_ledger_service.py` | No successful migration evidence | Model/mock tests only. | Not accepted |

## Repository State

- Current branch: `feature/pharmacy-module`.
- `git merge-base --is-ancestor HEAD phase1-stabilization` exit code: `1`; current `HEAD` is **not** merged into `phase1-stabilization`.
- Final verified `git status --short`: `?? docs/PHARMACY_P25_P34_UAT_ACCEPTANCE.md` only.
- Final verified `git diff --stat` and `git diff --cached --stat`: no output. The report is untracked and therefore not included in either diff stat.
- Final verified untracked-file list: `docs/PHARMACY_P25_P34_UAT_ACCEPTANCE.md`.
- P25-P29 commits on the current branch, newest first: `c2f0e14 P29 Fixes`, `dc1bc88 P29 changes`, `1d5954d P28 final commit`, `565da95 P28 Fixes`, `8e69253 P28 commits`, `0314d17 P27 check-in`, `07b7d0d commit upto P26 Pharamacy Feature`, `48cba63 pharamacy changes`, `265b409 pharamacy phase 1 changes`, `441b3b9 Pharamacy Commit upto P25.12`.
- Initial review snapshot had staged/unstaged/untracked P30/P31-P34 and Lab-related paths, including `0077_lab_test_master.py`, `0078_lab_order_id_invoice.py`, `0079_lab_order_facility.py`, `app/api/v1/lab.py`, `app/models/tenant/p31_p34.py`, `app/services/stock_ledger_service.py`, P30/P31-P34 test files, and frontend Lab Results work. This review did not create, edit, stage, reset, discard, or otherwise modify any of those paths; they are absent from the final worktree check.
- No merge, deployment, or Lab implementation was performed by this review.

## Warnings, Defects, And Required Corrections

No corrections were made during this evidence-only review.

| Blocker ID | Severity | Affected phase | Affected workflow | Evidence | Root cause | Required correction | Retest command |
|---|---|---|---|---|---|---|---|
| B-01 | Critical | P25-P34 | Backend regression | `228 passed, 72 failed, 42 errors`; exit `1` | Current branch has widespread test/runtime regressions, including Pharmacy files. | Investigate and correct each regression; preserve test strength. | `cd backend; python -m pytest tests -q` |
| B-02 | Critical | P30 | PostgreSQL returns, isolation, audit, ledger | `test_p30_comprehensive_acceptance.py` has six failed tests and two `pass` placeholders. | Async fixture uses `pytest.fixture` and returns an async generator; ledger tests contain no assertions. | Use correct async pytest fixture, isolated real PostgreSQL tenant schemas, real API/service calls, and non-placeholder concurrency/rollback assertions. | `cd backend; python -m pytest tests/test_p30_comprehensive_acceptance.py -v` |
| B-03 | Critical | P25-P34 | Migrations and E2E setup | `alembic upgrade head` exit `1`: duplicate `ix_lab_test_master_code`; Playwright global setup blocked. | Migration/index conflict in `0077` across configured tenant schema upgrades. | Repair migration idempotency/schema handling and validate from isolated clean and supported pre-Pharmacy PostgreSQL databases, including downgrade/re-upgrade policy. | `cd backend; python -m alembic upgrade head` |
| B-04 | High | P25-P34 | Browser acceptance | Playwright selected Chromium specs but executed 0 tests; exit `1`. | Port conflict first; migration failure second. | After migration repair, run Pharmacy, procurement, returns, transfer/count, RBAC, isolation, and OPD/prescription Playwright workflows against the real stack. | `cd frontend; npx playwright test --project=chromium --workers=1` |
| B-05 | High | P25-P34 | Frontend release build | Type-check exit `2`; production build exit `1`. | Seven TypeScript contract errors in `LabResultsPage.tsx`. | Resolve type/API contract errors or isolate approved unrelated work before Pharmacy release. | `cd frontend; npm run type-check; npm run build` |
| B-06 | High | P30-P34 | RBAC, tenant isolation, concurrency, reconciliation | No successful real-PostgreSQL two-tenant/application concurrency test; P31-P34 are model/mock assertions only. | Required acceptance suites have not been implemented/executed. | Add and run real PostgreSQL API integration tests and E2E tests for each required operation, role, tenant override vector, concurrent request, rollback, and ledger reconciliation. | Phase-specific real-stack pytest commands and Playwright commands, then full suite. |

## Deployment Prerequisites And Rollback

Deployment is prohibited for this review and is not approved. Before any UAT deployment: resolve every blocker, obtain isolated PostgreSQL clean/upgrade/downgrade evidence, achieve a green full backend suite and frontend build, and execute the required real-stack Playwright matrix. Confirm migration backups and a tested restore procedure. Rollback must use the project-approved Alembic rollback policy only after verifying reversibility and preserving transactional/audit data; no rollback was performed here.

## Final Decision

**NOT UAT READY**

## 2026-08-30 Remediation Attempt

The previous failed gate was remediated only where a contained root cause was verified. No deployment, merge, branch switch, Lab feature expansion, test weakening, xfail/skip conversion, or destructive shared-database action was performed.

### Corrections Completed

| Root cause | Correction | Validation |
|---|---|---|
| Revision `0077` caused duplicate index creation on new tenant tables because `op.create_table` columns used `index=True` and the migration then explicitly created the same named indexes. | Removed the four redundant inline `index=True` declarations. The named explicit indexes and existing-table idempotent repair path remain. This is backward compatible: databases already at `0077` do not rerun it; new/upgraded databases create each named index once. | Isolated PostgreSQL clean upgrade: exit `0`. Isolated existing-schema proof: `0049 -> 0080`, exit `0`, tenant `alembic_version=0080`. Downgrade/re-upgrade: `0080 -> 0076 -> 0080`, exit `0`; each `ix_lab_test_master_*` index counted once. Shared DB `alembic upgrade head`: exit `0`, `0080 (head)`. |
| `LabOrder.facility_id` referenced nonexistent `facilities.id` in ORM metadata while migration `0079` correctly made it a nullable indexed field only when no facilities table exists. | Removed only the invalid ORM foreign key; retained the nullable indexed field. | Playwright global setup proceeds through migration and E2E seeding. |
| P30 comprehensive tests received `async_generator` fixtures. | Changed shared `async_engine` and `async_session` fixtures to `pytest_asyncio.fixture`. | P30 comprehensive failures now execute real AsyncSession/database work rather than failing on an async-generator attribute error. |
| P30 router imported `require_permission` from the wrong module and treated JWT dictionaries as ORM Users. | Routed authorization through `app.core.dependencies.require_permission` using authenticated `sub` UUID values. | Local backend restarted healthy (`GET /health` 200). |
| P28 bill path sent invalid `billing_started_at` to `Invoice`, omitted paid amount for cash authorization, and did not invoke stock confirmation after cash authorization. | Removed invalid constructor/property writes; persist `paid_amount`; call existing `confirm_dispense_stock_consumption` inside the cash billing transaction. | Chromium P28 workflow: `1 passed`, exit `0`, 25.1s. Existing E2E assertions verify FEFO allocations, batch balances, and two stock ledger quantities (`-6.000`, `-4.000`). |
| P28 billing UI used pre-fulfillment dispense item data. | Refetch dispense items after fulfillment before assembling bill lines. | P28 E2E reached successful cash billing/confirmation. |
| Frontend Lab Results display used stale type fields. | Used existing `LabOrder.result` and `Visit.patient` types; removed unused import and unsafe query-parameter cast. | `npm run type-check`: exit `0`; `npm run lint`: exit `0`; `npm run test:unit`: 2 files / 5 tests passed, exit `0`; `npm run build`: exit `0`, 2,052 modules transformed. |

### Current Gate Results

| Working directory | Command | Actual result |
|---|---|---|
| `backend` | `python -m pytest tests/test_p30_returns.py -v` | `8 passed, 51 warnings in 0.42s`; exit `0`. SQLite/unit evidence only. |
| `backend` | `python -m alembic upgrade head` | `0080 (head)`; exit `0`. |
| `frontend` | `npm exec --no -- playwright test e2e/pharmacy-p28.spec.ts --project=chromium --workers=1` | Chromium: `1 passed`, `0 failed`, `0 skipped`, `0 retries`; exit `0`. |
| `frontend` | `npm run type-check` | exit `0`. |
| `frontend` | `npm run lint` | exit `0`. |
| `frontend` | `npm run test:unit` | 2 files / 5 tests passed; exit `0`. Zustand test-storage warning is non-blocking. |
| `frontend` | `npm run build` | exit `0`. Vite chunk-size warning (751.66 kB) is non-blocking. |
| `backend` | `python -m pytest tests -q` | `237 passed, 80 failed, 25 errors, 112 warnings in 74.26s`; exit `1`. |

### Remaining Blockers

| Blocker ID | Severity | Phase | Workflow | Evidence | Root cause | Correction required | Exact retest command |
|---|---|---|---|---|---|---|---|
| B-01 | Critical | P25-P34 | Full backend regression | `237 passed, 80 failed, 25 errors`; exit `1`. | Shared event-loop fixture/lifecycle failures, migration-fixture failures, and database cross-test contamination remain. | Stabilize the async test harness and isolate real-PostgreSQL fixtures; fix all resulting valid product/test defects without weakening coverage. | `cd backend; python -m pytest tests -q` |
| B-02 | Critical | P30 | PostgreSQL returns/concurrency/ledger | `test_p30_comprehensive_acceptance.py` is not a valid tenant-schema acceptance suite; two ledger methods remain placeholders. | Test was written against public schema without prerequisite tenant data; return service lacks demonstrated concurrent locking/idempotency contract. | Replace placeholders with isolated two-tenant PostgreSQL API/service tests covering full/partial return, rollback, exact ledger state, duplicate/idempotent replay, and independent-session concurrency. | `cd backend; python -m pytest tests/test_p30_comprehensive_acceptance.py -v` |
| B-03 | Critical | P31-P34 | Operational workflows | No real PostgreSQL/API/browser acceptance test exists. | Current P31-P34 tests are model/mock construction assertions only. | Implement and execute operational backend/API/RBAC/isolation/concurrency/ledger tests and corresponding browser workflows for quarantine/recall, transfer, count, and reporting. | Phase-specific PostgreSQL pytest plus Chromium Playwright commands |
| B-04 | High | P25 | Formulary search | `test_formulary_medicine_search_phase25.py::test_search_excludes_future_expired_unapproved_and_inactive_records` fails. | Product or test-date behavior needs verification against current date/acceptance rule. | Diagnose and correct the active/effective/expiry filter or update only a demonstrably stale fixed-date test. | `cd backend; python -m pytest tests/test_formulary_medicine_search_phase25.py -v` |
| B-05 | High | P26 | GRN workflow | Five GRN tests fail with `422: received_date cannot be in the future`. | Fixed test data has become future-dated relative to the current date. | Replace stale fixed dates with an approved current/past test date after verifying no production regression. | `cd backend; python -m pytest tests/test_goods_receipt_workflow_phase26.py tests/test_grn_batch_expiry_phase26.py -v` |
| B-06 | High | P25-P34 | Required E2E/RBAC/isolation matrix | Only P25 prescription and P28 dispensing browser coverage has run. | Required P26-P34 workflows and RBAC/two-tenant browser/API coverage are missing. | Add and run the mandatory browser and real-backend authorization/isolation workflows. | `cd frontend; npm exec --no -- playwright test --project=chromium --workers=1` |

The final decision remains **NOT UAT READY**. The migration, frontend quality, and P28 browser blockers are corrected, but mandatory P30 real-PostgreSQL acceptance, P31-P34 operational evidence, RBAC/isolation/concurrency/reconciliation evidence, and the green full backend gate remain incomplete.

### Final Repository Snapshot

Final branch: `feature/pharmacy-module`. `git merge-base --is-ancestor HEAD phase1-stabilization` returned exit `1`; no merge into `phase1-stabilization` occurred. The report is staged (`A  docs/PHARMACY_P25_P34_UAT_ACCEPTANCE.md`) but no commit was created. The remediation worktree contains modifications to the migration, P30 API/test fixture, Pharmacy bill flow, Lab ORM display compatibility, P28 E2E, and frontend display files. `git diff --stat` (unstaged) reports `backend/app/api/v1/pharmacy.py | 10 +++++++++-`; `git diff --cached --stat` reports 9 files changed, 318 insertions, 52 deletions. No deployment was performed.

### 2026-08-30 P25/P26 Date Remediation

The P25 formulary test used local `date.today()` while the production search uses `datetime.now(timezone.utc).date()`. Around local midnight this made its "expired yesterday" record equal to the production date and therefore correctly visible. The test now uses the same UTC business-date source. P26 had the same production contract mismatch: `GoodsReceiptCreate` defaulted `received_date` from local `date.today()` but the endpoint rejected dates later than the UTC business date. The schema default now uses `datetime.now(timezone.utc).date()`. GRN test expiry fixtures are relative to that business date rather than fixed calendar years; future-manufacture and expired-batch negative assertions remain.

Validated command from `D:\Personal\HMS\HMS-tenant\backend`: `python -m pytest tests/test_formulary_medicine_search_phase25.py tests/test_goods_receipt_workflow_phase26.py tests/test_grn_batch_expiry_phase26.py -q` produced `11 passed, 1 warning in 2.01s`, exit `0`. The warning is the existing `pytest-asyncio` unset default loop scope/custom event-loop fixture deprecation.

### 2026-08-30 P26 Purchase-Order Date Remediation

`PurchaseOrderCreate.po_date` had the same local `date.today()` default while `create_purchase_order` validates against UTC. The default now uses `datetime.now(timezone.utc).date()`, preserving rejection of explicit future dates while preventing midnight-dependent failures for valid defaulted orders. Validated from `D:\Personal\HMS\HMS-tenant\backend`: `python -m pytest tests/test_purchase_order_workflow_phase26.py -v` produced `5 passed in 1.34s`, exit `0`; warnings were the existing pytest-asyncio default-loop/custom-loop deprecations.

After the P25/P26 fixes, the prior complete Pharmacy-focused run had `130 passed, 11 failed, 106 warnings in 21.48s`, exit `1`. Five failures were the now-corrected purchase-order UTC-date cluster; the six remaining failures are `test_p30_comprehensive_acceptance.py` attempts to write tenant-domain tables through the shared public-schema session. They cannot be accepted or fixed by weakening tests: the module must be rebuilt as an isolated tenant-schema real PostgreSQL suite with migrated prerequisite data, independent sessions for concurrency, authenticated API RBAC/isolation checks, and non-placeholder ledger/rollback assertions.

### 2026-08-30 Fresh Baseline And P30 Design Blocker

Fresh valid baseline commands from `D:\Personal\HMS\HMS-tenant\backend` used explicit PowerShell test-file expansion (the initial literal-glob attempt executed zero tests and is not evidence):

| Command | Result |
|---|---|
| `python -m pytest -q <all P25 phase test files>` | `48 passed`; exit `0` |
| `python -m pytest -q <all P26 phase test files>` | `28 passed`; exit `0` |
| `python -m pytest -q <all discovered P25-P34 Pharmacy-focused files>` | `135 passed, 6 failed, 106 warnings in 13.00s`; exit `1` |
| `python -m pytest tests/test_p30_returns.py -v` | `8 passed, 51 warnings in 0.42s`; exit `0` (mock/SQLite-style service evidence only) |
| `python -m pytest tests/test_p30_comprehensive_acceptance.py -v` | six failures; current suite incorrectly uses the public-schema session for tenant-domain tables and two ledger tests are placeholders |
| `python -m pytest tests -q` | `244 passed, 73 failed, 25 errors`; exit `1` |

The six current focused-suite failures are all in `test_p30_comprehensive_acceptance.py`; the P25-P29 focused groups are green in the fresh consolidated run. Full raw command output is retained locally in `.acceptance-artifacts/2026-08-30/`. The final repository check shows those evidence artifacts are staged; this review preserved that existing index state without unstage/reset operations.

P30 implementation has a material inventory-traceability ambiguity that prevents a correct tenant-schema acceptance redesign without an approved business rule. P28 supports one dispense item allocated across multiple FEFO batches. `PatientReturnItem` has only one nullable `inventory_batch_id`, while `UniqueConstraint("return_id", "dispense_item_id", name="uq_patient_return_items_return_dispense")` prevents recording multiple batch allocations for the same dispense item in one return. The P30 request schema does not identify a batch, and the service never derives one from dispensing allocations. Consequently, the requested patient return cannot be correctly reconciled to all original batches, ledger rows, stock valuation, or subsequent partial returns.

The required decision is whether a patient return must: (a) be allocated proportionally across the original dispensing allocations, (b) be returned in explicit pharmacist-selected batch quantities, or (c) follow a documented FEFO/new-batch restocking rule. Options (a) and (b) require an additive `patient_return_item_allocations` model/migration and a corresponding API contract; option (c) changes valuation/traceability semantics. This review will not select an inventory allocation policy unilaterally.

Placeholder scan across 66 P25-P34/pharmacy/inventory/return/ledger-related test files found exactly two P30 acceptance placeholders: `test_p30_comprehensive_acceptance.py` ledger integration and reversal tests. No `assert True`, `TODO`, `FIXME`, `NotImplemented`, `xfail`, unconditional early return, or P25-P34 acceptance skip was found. Other standalone `pass` hits are unrelated WebSocket/test-helper implementations; PostgreSQL `skipif` markers are environment-availability guards.

### 2026-08-30 Approved Explicit-Batch P30 Implementation

The approved patient-return policy requires explicit pharmacist-selected allocations to original dispensing batches. The implementation adds `PatientReturnBatchAllocation`, with tenant ID, return-item parent, original `PharmacyDispenseAllocation`, original `InventoryBatch`, positive returned quantity, original unit cost, optional stock-ledger reference, creator, timestamps, and a uniqueness constraint on `(patient_return_item_id, dispense_allocation_id)`. The existing `PatientReturnItem.inventory_batch_id` remains legacy compatibility data and is populated only for an unambiguous single-allocation return; new allocation rows are authoritative.

Patient return request validation now locks the authenticated tenant dispense, its items, and consumed original dispensing allocations. It rejects missing allocations for multi-batch dispensing, empty allocations, duplicate batches, allocation-total mismatch, unrelated batches, cross-tenant batches, and quantities exceeding the cumulative remaining quantity of the original allocation. A legacy request without allocations is accepted only where exactly one original batch allocation exists. The previous blanket single-active-return rejection was removed because the approved policy permits multiple partial returns up to allocation-level remaining quantity.

Patient return acceptance now locks return items/allocation rows in deterministic batch order and writes one `PATIENT_RETURN_RESTOCK` ledger row per allocation using `PatientReturnBatchAllocation` as the source reference. The shared ledger helper now locks inventory batch rows with `SELECT FOR UPDATE` while calculating and applying the balance change. This preserves per-batch valuation and does not create a new batch or apply FEFO/proportional restoration.

Migration `0081_patient_return_batch_allocations.py` is additive after `0080`. It creates the allocation table and indexes without altering existing return rows, and backfills legacy single-batch rows only where a matching original dispensing allocation has sufficient confirmed quantity. Ambiguous history remains legacy-only for review rather than being silently guessed. Command from `D:\Personal\HMS\HMS-tenant\backend`: `python -m alembic upgrade head; python -m alembic current` completed with exit `0`; public and all active tenant schemas report `0081 (head)`.

The attempted disposable clean-database validation for `0081` was invalid: its wrapper used an unavailable host `psql`, so the temporary database was never created and its migration result is not claimed. A proper Docker-`psql` isolated clean/existing/downgrade validation remains required.

The existing mock-focused `tests/test_p30_returns.py` currently has `3 failed, 5 passed, 43 warnings`, exit `1`, because its mock session has no consumed `PharmacyDispenseAllocation` data and its duplicate-return assertion tests a rule superseded by approved multiple partial returns. It must be updated alongside the required real tenant-schema acceptance module; this is not counted as passing evidence. `test_p30_comprehensive_acceptance.py` still has the two placeholder ledger tests and invalid public-schema design. P30 remains **NOT UAT READY**.

### 2026-08-30 P30 Implementation-To-Acceptance Repair

The focused mock suite now models a consumed original `PharmacyDispenseAllocation`, its original batch, per-batch allocation quantity, ledger invocation, and allocation-level remaining eligibility. The obsolete "single active return" test was replaced with cumulative over-return rejection; the approved policy permits multiple partial returns until the original batch allocation is exhausted. Command from `D:\Personal\HMS\HMS-tenant\backend`: `python -m pytest tests/test_p30_returns.py -v` produced `8 passed, 48 warnings`, exit `0`.

`tests/test_p30_comprehensive_acceptance.py` has been rebuilt. It no longer uses the public-schema session or placeholder bodies. It creates two isolated PostgreSQL tenant schemas, asserts `SELECT current_schema()` and `SHOW search_path`, creates tenant-domain tables within each schema, and seeds a deterministic two-batch consumed dispense. Its real PostgreSQL tests verify explicit multi-batch return restoration and one ledger row per selected original batch, invalid unrelated-batch rejection with no committed return, and idempotency replay without a duplicate return. Command: `python -m pytest tests/test_p30_comprehensive_acceptance.py -q` produced `3 passed, 25 warnings`, exit `0`. Combined command: `python -m pytest tests/test_p30_returns.py tests/test_p30_comprehensive_acceptance.py -q` produced `11 passed, 67 warnings in 7.46s`, exit `0`.

P30 migration chain now has two additive revisions: `0081` creates authoritative patient return batch allocations and backfills only valid matching historical single-batch rows; `0082` adds patient-return idempotency persistence plus live P30 permissions for pharmacist and hospital administrator roles. The configured shared PostgreSQL upgrade reports `0082 (head)`. A clean migration was also executed correctly through Docker: database `hms_p30_clean_20260830` was created through `docker exec hospital_postgres psql`, its existence was verified with `SELECT datname FROM pg_database`, backend Alembic targeted `postgresql+asyncpg://hospital_user:***@localhost:5433/hms_p30_clean_20260830`, `python -m alembic upgrade head` and `python -m alembic current` completed with exit `0`, and `public.alembic_version` reported `0082`. Connections were terminated and only that temporary database was dropped.

Remaining P30 acceptance gaps are explicit and blocking: route-level real ASGI API tests for authorization/tenant isolation, independent-session concurrent return tests, supplier-return/idempotency coverage, controlled post-preparation rollback injection, and browser patient-return workflow coverage have not yet been implemented. The final decision remains **NOT UAT READY**.

### 2026-08-30 P30 ASGI Boundary Repair

The returns router previously declared its own `/api/v1` prefix even though the application mounts the API router at `/api/v1`; P30 endpoints were therefore unreachable at the expected path. The router now mounts at `/api/v1/returns/...`, verified from the real backend OpenAPI document. Supplier-return location lookup also no longer references nonexistent `PharmacyLocation.is_primary`; it selects the active `PHARMACY` location in the authenticated tenant/facility.

The authentication boundary was corrected so missing bearer credentials return `401` instead of FastAPI `HTTPBearer`'s default `403`. `get_current_user` now verifies that a tenant JWT's `tenant_id` is the same tenant as the loaded public user, preventing a user identity from being paired with another tenant's signed claim. The P30 ASGI fixture creates distinct public Tenant A/Tenant B pharmacist users and signed role-bearing JWTs, rather than using forged cross-tenant identity claims.

Migration `0083_p30_return_request_hash.py` adds a canonical SHA-256 request hash for each idempotent patient-return request. Replaying the same key and identical payload returns the original return; reusing that key with a materially different payload returns `400` without a second return. The configured PostgreSQL upgrade reached `0083 (head)` successfully.

Command from `D:\Personal\HMS\HMS-tenant\backend`: `python -m pytest tests/test_p30_comprehensive_acceptance.py -q` produced `4 passed, 49 warnings in 13.37s`, exit `0`. It covers tenant schema/search path, exact multi-batch restock and ledger allocation, unrelated-batch rollback, direct idempotent service replay, and real ASGI `401` unauthenticated, `403` unauthorized nurse, pharmacist create/replay/conflict, and Tenant B `404` read isolation behavior.

Combined P30 command after the ASGI boundary work: `python -m pytest tests/test_p30_returns.py tests/test_p30_comprehensive_acceptance.py -q` produced `12 passed, 88 warnings in 13.13s`, exit `0`. Warnings are non-blocking pre-existing pytest-asyncio/Pydantic/Python datetime deprecations plus SQLAlchemy's known invoices/pharmacy-dispenses foreign-key cycle warning in metadata ordering.

Mandatory gaps remain: supplier-return PostgreSQL/API acceptance, independent-session concurrency scenarios, controlled rollback injection, full return lifecycle HTTP coverage, P30 Playwright workflow, and all P31-P34 operational evidence. The full backend suite has not been rerun to a green exit after these changes. Final decision remains **NOT UAT READY**.

### 2026-08-30 Supplier Return And Fresh Pharmacy Regression

Supplier return now has tenant/facility-scoped source validation before a business record is created. The service locks the active supplier, optional goods receipt, and returned inventory batches in deterministic batch-ID order; rejects duplicate batch rows, inactive/missing supplier, wrong location/tenant/facility, supplier mismatch, GRN mismatch, and excess available batch quantity; and records `received_quantity` from the validated source batch. Additive migration `0084_supplier_return_idempotency.py` adds tenant-scoped supplier return idempotency and canonical request hashes. Identical request-key replay returns the original return; a different hash is rejected.

The real tenant-schema PostgreSQL fixture now seeds Supplier -> Purchase Order -> Goods Receipt -> Inventory Batch provenance. Command from `D:\Personal\HMS\HMS-tenant\backend`: `python -m pytest tests/test_p30_comprehensive_acceptance.py -q` produced `6 passed, 78 warnings in 13.64s`, exit `0`. It verifies supplier return request, approval, dispatch, exact batch reduction from `10` to `6`, `SUPPLIER_RETURN` ledger quantity `-4`, correct prior/new ledger balances, tenant and batch linkage, and the real ASGI route's `401` unauthenticated, `403` unauthorized, authorized create, identical replay, and excess-quantity rejection. Combined P30 command produced `14 passed, 120 warnings`, exit `0`.

Fresh existing Pharmacy-focused regression command from `D:\Personal\HMS\HMS-tenant\backend`: `python -m pytest -q` over the established 27 P25-P34 Pharmacy files produced `139 passed, 160 warnings in 24.09s`, exit `0`. Warning classes are existing pytest-asyncio loop configuration/custom-loop deprecations, Pydantic v2 deprecations, Python `datetime.utcnow()` deprecations, JWT dependency deprecations, and SQLAlchemy's known `invoices`/`pharmacy_dispenses` metadata-sort cycle warning.

This green focused regression does not constitute full P30 acceptance. Required unimplemented evidence remains: independent-session concurrency cases (including idempotency race handling), controlled patient/supplier rollback injection and fresh-session verification, complete route lifecycle matrices, P30 browser workflows, final isolated existing-schema/downgrade validation through `0084`, full backend suite exit `0`, and P31-P34 operational acceptance. Final decision remains **NOT UAT READY**.

### 2026-08-30 Fresh Baseline

Complete command transcripts are saved locally in `.acceptance-artifacts/2026-08-30/` and are not staged. All commands used `D:\Personal\HMS\HMS-tenant\backend` with `DATABASE_URL=postgresql+asyncpg://hospital_user:hospital_pass@localhost:5433/hospital`, `SECRET_KEY=test-secret-key`, and `REDIS_URL=redis://localhost:6379`.

| Command | Result | Exit code |
|---|---|---|
| `python -m pytest -q` over all `*phase25.py` files | `48 passed, 1 warning in 2.33s` | `0` |
| `python -m pytest -q` over all `*phase26.py` files plus `test_grn_batch_expiry_phase26.py` | `28 passed, 1 warning in 3.32s` | `0` |
| `python -m pytest tests/test_p30_returns.py -q` | `8 passed, 51 warnings in 0.29s` | `0` |
| `python -m pytest tests/test_p30_comprehensive_acceptance.py -q` | `6 failed, 2 passed, 22 warnings in 6.13s` | `1` |
| Explicit complete P25-P34 Pharmacy-focused inventory | `135 passed, 6 failed, 106 warnings in 13.00s` | `1` |
| `python -m pytest tests -q` | `244 passed, 73 failed, 25 errors, 118 warnings in 73.62s` | `1` |

The requested first baseline used literal PowerShell wildcards (`tests/test_*phase25.py` and `tests/test_*phase26.py`), which PowerShell did not expand for the native pytest invocation. Those commands ran zero tests and are not used as evidence; their replacement commands above use explicit `Get-ChildItem` expansion. The full backend failure transcript is retained in `.acceptance-artifacts/2026-08-30/full-backend.txt` for root-cause clustering.

Fresh focused-suite cluster table:

| Cluster ID | Error signature | Tests | Root cause | Status / retest |
|---|---|---:|---|---|
| P30-TS-01 | PostgreSQL programming errors when tests write tenant models via shared public-schema session | 6 | Invalid P30 comprehensive test architecture; missing isolated migrated tenant schemas and prerequisite data. | Open. `cd backend; python -m pytest tests/test_p30_comprehensive_acceptance.py -v` |
| P30-TS-02 | `pass` bodies in ledger acceptance tests | 2 collected tests | No ledger assertions exist. | Open. Replace with real tenant-schema transaction/ledger/rollback assertions. |
| FULL-ASYNC-01 | `RuntimeError: There is no current event loop in thread 'MainThread'` | Multiple non-Pharmacy and Pharmacy tests in full suite | Shared legacy event-loop fixture lifecycle remains incompatible with current pytest-asyncio behavior. | Open. `cd backend; python -m pytest tests -q` |
| FULL-DB-01 | PostgreSQL integrity/programming errors in cross-tenant/document fixtures | Multiple full-suite errors | Test isolation/schema cleanup and shared fixture setup require remediation. | Open. `cd backend; python -m pytest tests -q` |

No P30, P31, P32, P33, or P34 requirement is accepted from this baseline. The final decision remains **NOT UAT READY**.

### 2026-08-30 Supplier P30 Gate Update

The real PostgreSQL tenant-schema supplier fixture now proves Supplier -> Purchase Order -> Goods Receipt -> source Inventory Batch provenance. Supplier-return service validation locks the supplier, optional GRN, and source batches in deterministic order; checks tenant/facility/location/supplier/GRN consistency; rejects duplicate batch entries and excess available stock; and persists the source received quantity. Migration `0084` adds supplier idempotency and canonical request hashing.

### 2026-08-30 P30 Frontend Integration Attempt

The P30 return pages no longer use hard-coded production batch IDs or return records. `PatientReturnsPage.tsx` now searches and selects authenticated-tenant eligible dispenses, renders original per-batch allocations and remaining quantities, validates positive and bounded allocation totals, submits explicit `batch_allocations`, retains one idempotency key through a retry, and refreshes return/eligibility queries on success. `SupplierReturnsPage.tsx` now loads active suppliers and eligible real inventory batches, validates multi-batch quantities, submits backend-supplied batch cost, and only shows approve for `REQUESTED` returns and dispatch for `APPROVED` returns. Existing `FeatureGuard` plus `RoleGuard` continue to hide navigation and block direct routes for non-pharmacy roles; the backend remains permission-authoritative.

Frontend integration exposed a missing patient selection contract and incomplete eligibility response. The backend now provides protected `GET /returns/patient-returns/eligible-dispenses` and enriches `GET /returns/patient-returns/eligibility/{dispense_id}` with patient/dispense/prescription/invoice information plus persisted previous-return quantities. Supplier eligibility now supplies the authoritative batch purchase rate for the create payload. These are contained P30 contract repairs, not a backend-only pass.

Observed commands and results:

| Working directory | Command | Result |
|---|---|---|
| `backend` | `python -m pytest tests/test_p30_returns.py tests/test_p30_comprehensive_acceptance.py -q` | `17 passed, 139 warnings in 12.76s`; exit `0`. Warnings are existing Pydantic, UTC datetime, JWT, and metadata-cycle deprecations. |
| `frontend` | `npm run type-check` | Passed; exit `0`. |
| `frontend` | `npm run lint` | Passed with `0` warnings; exit `0`. |
| `frontend` | `npm run test:unit` | `2` suites / `5` tests passed, `0` failed, `0` skipped; exit `0`. Five non-blocking Zustand test-storage warnings. |
| `frontend` | `npm run build` | Passed; exit `0`. One Vite >500 kB output-chunk warning. |
| `frontend` | `npx playwright test e2e/pharmacy-p28.spec.ts --project=chromium --workers=1` with `E2E_MANAGED_BACKEND=false`, `E2E_ENVIRONMENT=E2E`, `E2E_ALLOW_DESTRUCTIVE_RESET=true` | Chromium `1 passed`, `0` failed, `0` skipped, `0` retries; exit `0`. HTML report: `frontend/playwright-report/`. |

This is not a completed frontend/browser P30 gate. No new P30 Vitest component suite has been added or executed, and no P30 Chromium spec or deterministic P30 seed/reset workflow has yet run. The sole Chromium attempt before setting `E2E_MANAGED_BACKEND=false` executed zero tests because port `8000` was already occupied; it generated no artifacts. Consequently, required browser proof for patient multi-batch return/replay/unauthorized behavior and supplier create/approve/dispatch/inventory/replay/unauthorized behavior remains absent. P30 remains **NOT UAT READY**.

### 2026-08-30 P30 Component Acceptance Update

P30-specific jsdom component coverage is now present in `frontend/src/features/pharmacy/PatientReturnsPage.test.tsx` and `frontend/src/features/pharmacy/SupplierReturnsPage.test.tsx`. The tests mock only return/master-data service boundaries and exercise rendered React controls. Patient coverage includes loading/error/empty states, displayed patient/prescription/dispense/invoice/medicine/allocation values, single and multi-batch payload construction, calculated item quantity, zero/negative/excess rejection, field-error display, idempotency-key replay, pending-click prevention, success display, and query refresh. Supplier coverage includes supplier loading/error/empty states, active-supplier filtering, supplier-to-batch eligibility, GRN/location/batch quantity display, backend unit-cost payload use, multi-batch submission, excess rejection, and status-restricted approve/dispatch invocation.

Fresh frontend gate commands from `D:\Personal\HMS\HMS-tenant\frontend`:

| Command | Result | Exit code |
|---|---|---:|
| `npx vitest run src/features/pharmacy/PatientReturnsPage.test.tsx src/features/pharmacy/SupplierReturnsPage.test.tsx --reporter=dot` | `2` files / `10` tests passed; `0` failed, `0` skipped | `0` |
| `npm run type-check` | Passed, no diagnostics | `0` |
| `npm run lint` | Passed, zero warnings | `0` |
| `npm run test:unit` | `4` files / `15` tests passed; `0` failed, `0` skipped. P30 component subset: `10` passed. | `0` |
| `npm run build` | Passed. Vite produced one non-blocking >500 kB output-chunk warning (`771.26` kB). | `0` |

No P30 deterministic E2E seed/reset command or P30 Chromium spec has executed in this update. The patient/supplier real-browser workflows, real PostgreSQL inventory/ledger post-condition assertions, and browser RBAC direct-route/403 proof are therefore still mandatory blockers. P30 remains **NOT UAT READY**.

### 2026-08-30 P30 Seed And Chromium Attempt

`backend/tests/e2e_seed_task7.py` now provides deterministic `seed_p30_scenario` and `reset_p30_scenario` commands. They use isolated UUIDs for single-batch and multi-batch confirmed dispenses, original consumed allocation batches, a P30 pharmacy location, an eligible GRN, and two eligible supplier batches. The reset deletes only P30 return headers/items/allocations, supplier returns/items, ledger rows, allocation rows, source dispenses, P30 inventory batches, GRN, visits, patients, and location. It preserves P25/P28 fixture IDs and shared base tenant users. The seed was executed, reset, and executed again with exit `0`; the only warning was the existing SQLAlchemy invoice/dispense metadata-order cycle.

The real Chromium command executed from `frontend` was:

`$env:E2E_ENVIRONMENT='E2E'; $env:E2E_ALLOW_DESTRUCTIVE_RESET='true'; $env:E2E_MANAGED_BACKEND='false'; npx playwright test e2e/pharmacy-p30-patient-returns.spec.ts e2e/pharmacy-p30-supplier-returns.spec.ts --project=chromium --workers=1`

It executed with the real frontend, FastAPI backend, PostgreSQL E2E tenant, login, and route guards. Exit `1`: `2 failed`, `2 did not run`. The patient test successfully authenticated and reached Patient Returns, then timed out selecting the filtered record because the real `Eligible dispensing record` control remained disabled (`eligible` query did not settle within 30 seconds). This is a live eligibility/API integration blocker. The supplier test was not accepted because the group stopped at the blocking setup state. Failure artifacts include `frontend/test-results/pharmacy-p30-patient-retur-cd905-ent-return-through-Chromium-chromium/error-context.md` and `frontend/test-results/pharmacy-p30-supplier-retu-f05ff-ier-return-through-Chromium-chromium/trace.zip`, with screenshot/video/diagnostic attachments beneath the latter directory. HTML report: `frontend/playwright-report/`.

P30 Chromium acceptance is therefore not complete. Required inventory/ledger post-condition, repeated-submit, supplier lifecycle, and browser authorization assertions have not passed and remain blocking. P30 remains **NOT UAT READY**.

### 2026-08-30 Live Eligibility Repair And Chromium Rerun

The initial disabled-select diagnosis was completed at the HTTP boundary. Browser diagnostics recorded `405 Method Not Allowed` and `422 Unprocessable Entity` responses from the pre-existing backend on port `8000`; its OpenAPI document did not contain `/api/v1/returns/patient-returns/eligible-dispenses`. The request was not hanging. A source backend was started locally on `127.0.0.1:8001` and Vite was started on `127.0.0.1:4174` with `VITE_BACKEND_TARGET=http://127.0.0.1:8001` so the real browser used the checked-out route implementation.

The source OpenAPI document contains the exact static eligibility route. Direct authenticated source probing then showed login `200` with role `pharmacist`, tenant schema `e2e_task7`, and pharmacy feature, but eligibility returned `403 {"detail":"Facility context is missing"}`. The production cause was that login/refresh/password-change JWT creation did not issue a facility claim while P30 routes correctly require facility scope. `auth.py` now resolves a facility only when the authenticated tenant has exactly one active pharmacy facility, adds that server-derived `facility_id` claim to tenant-user access tokens, and preserves it on refresh/password change. It does not accept a client-supplied facility header or change tenant/permission enforcement. After reseed, direct source probe was login `200`, claim `facility_id=016e30e1-d9b4-555f-b538-7ce7747376a3`, eligibility `200`, JSON array count `2`, containing exactly `E2E-P30-SINGLE` and `E2E-P30-MULTI`.

The guarded E2E cleanup was needed before Playwright global setup after manual source probing; global setup migrates before creating the `create_all` E2E schemas. With that established lifecycle, real Chromium workflows were executed through Vite `4174` and source FastAPI `8001`:

| Command | Result | Exit code |
|---|---|---:|
| `npx playwright test e2e/pharmacy-p30-patient-returns.spec.ts --project=chromium --workers=1` with `E2E_BASE_URL=http://127.0.0.1:4174`, `E2E_MANAGED_BACKEND=false`, `E2E_ENVIRONMENT=E2E`, `E2E_ALLOW_DESTRUCTIVE_RESET=true` | `3 passed`: single-batch patient return, multi-batch patient return, unauthorized receptionist direct-route block | `0` |
| `npx playwright test e2e/pharmacy-p30-supplier-returns.spec.ts --project=chromium --workers=1` with the same environment | `1 passed`: real supplier return create, approve, dispatch | `0` |
| Combined two P30 specs, same environment | `4 passed`, `0` failed, `0` skipped, `0` retries | `0` |
| Repeated combined two P30 specs, same environment | `4 passed`, `0` failed, `0` skipped, `0` retries | `0` |

The P30 seed ran before each Chromium case. The only run warning was the existing SQLAlchemy metadata-order cycle between `invoices` and `pharmacy_dispenses`; it did not prevent migration, authentication, or browser execution. HTML report: `frontend/playwright-report/`. The earlier failed artifacts remain at `frontend/test-results/pharmacy-p30-patient-retur-cd905-ent-return-through-Chromium-chromium/` and `frontend/test-results/pharmacy-p30-supplier-retu-f05ff-ier-return-through-Chromium-chromium/` for the stale-backend evidence.

These real-browser tests establish that eligibility loads and the basic patient single/multi and supplier lifecycle UI routes execute against real PostgreSQL. They do not yet establish the full P30 acceptance matrix: the current specs do not assert database inventory/ledger counts after browser actions, rapid duplicate submission, validation/error cases, direct API `403` checks, or the full fresh backend/browser regression matrix. Those gaps remain blocking for P30 UAT acceptance. Final status remains **NOT UAT READY**.

### 2026-08-30 P30 Snapshot Post-Condition Attempt

The P30 E2E seed now exposes `snapshot_p30`, a test-only command scoped to deterministic P30 batch IDs and return records. It reports batch balances, patient return/allocation rows, supplier return rows, and `PATIENT_RETURN_RESTOCK`/`SUPPLIER_RETURN` ledger rows. Baseline snapshot after `seed_p30_scenario` is correct: patient source batches are `0.000`, supplier batches are `10.000` and `8.000`, and no P30 returns or return ledger rows exist.

The first updated patient Chromium execution reached the real patient-return create request, but the snapshot initially failed only because a `Decimal` header value was not JSON serializable. That test-helper serializer was corrected. The rerun then failed the intended ledger post-condition: the browser-created patient return remains `REQUESTED`; the expected source allocation/stock movement is not committed at request creation. Snapshot observed returned allocation quantity `0.000` where the browser request quantity was `2.000` and no restock ledger row exists. This matches the backend lifecycle, where restocking occurs only after separate `validate -> accept` actions.

The current Patient Returns page exposes request creation but no validate/accept lifecycle controls. Therefore it cannot provide the required browser proof that a patient-return submission increases stock and writes `PATIENT_RETURN_RESTOCK` ledger rows without either adding those lifecycle actions to the UI or changing the approved backend lifecycle. This is a P30 high-severity acceptance blocker, not a Playwright timeout. The affected execution was `npx playwright test e2e/pharmacy-p30-patient-returns.spec.ts --project=chromium --workers=1` against source FastAPI `8001` via Vite `4174`: `4` scheduled, first test failed at the exact allocation assertion, remaining `3` did not run, exit `1`.

No P31-P34 implementation was started because P30 is not accepted.

### 2026-08-30 Supplier Chromium Completion

The supplier Chromium workflow was rerun in an isolated child process against source FastAPI `8001`, Vite `4174`, real PostgreSQL, and the deterministic P30 seed. Command executed from `frontend`: `npx playwright test e2e/pharmacy-p30-supplier-returns.spec.ts --config=playwright.config.ts --project=chromium --workers=1` with `E2E_BASE_URL=http://127.0.0.1:4174`, `E2E_MANAGED_BACKEND=false`, `E2E_ENVIRONMENT=E2E`, and `E2E_ALLOW_DESTRUCTIVE_RESET=true`. Playwright result: `1 passed` in `34.2s`.

The browser spec verifies create -> approve -> dispatch, the scoped snapshot confirms `DISPATCHED`, P30-SUP-A inventory `10.000 -> 8.000`, and exactly one `SUPPLIER_RETURN` ledger entry with `-2.000`. It then calls the real dispatch endpoint again with the authenticated request header, receives `400`, and verifies the batch remains `8.000` with no second ledger row. The PowerShell `Start-Process` wrapper did not populate its `ExitCode` property after the child-process wait (`EXIT_CODE=`); this is an orchestration reporting limitation, not an ambiguous test result because Playwright emitted its definitive `1 passed` summary.

The supplier service/ASGI assertions verify the source batch reduces from `10` to `6`, a single `SUPPLIER_RETURN` ledger entry is posted at `-4`, tenant and batch IDs match, and the ledger stores `previous_balance=10` and `new_balance=6`. Route coverage verifies `401` missing credentials, `403` unauthorized nurse, authorized pharmacist creation, identical replay returning the original return, and `400` excess-balance rejection. The comprehensive suite produced `6 passed, 78 warnings in 13.64s`, exit `0`; the combined P30 suite produced `14 passed, 118 warnings in 14.96s`, exit `0`. The final existing Pharmacy-focused inventory produced `139 passed, 160 warnings in 24.09s`, exit `0`.

P30 remains not accepted: real independent-session concurrency, controlled patient/supplier rollback verification, complete lifecycle API matrix, P30 Chromium workflows, and final migration downgrade/existing-schema checks through `0084` remain unexecuted. P31-P34 operational acceptance and a green full backend suite are also mandatory remaining blockers. Final decision: **NOT UAT READY**.

### 2026-08-30 Fresh Full Backend Regression

Fresh command from `D:\Personal\HMS\HMS-tenant\backend`: `python -m pytest tests -q` completed with `248 passed, 67 failed, 25 errors, 163 warnings in 77.57s`, exit `1`. Complete output is retained at `.acceptance-artifacts/2026-08-30/full-backend-after-p30.txt`.

| Cluster | Representative evidence | Root cause / status |
|---|---|---|
| FULL-ASYNC-01 | Queue, RBAC, realtime, reception, Redis fallback, session invalidation, P26 supplier and P27 stock tests fail with `RuntimeError: There is no current event loop in thread 'MainThread'`. | Shared legacy custom event-loop fixture is incompatible with the current pytest-asyncio lifecycle. Blocking shared test infrastructure defect. |
| FULL-DB-01 | Document integrity, refresh-token versioning, and tenant-isolation modules error during PostgreSQL setup. | Independent real-PostgreSQL schemas/fixtures are not isolated reliably across the full ordered suite. Blocking shared test infrastructure defect. |
| FULL-DATE-01 | P26 purchase-order workflow failures reappear in the full suite. | Test process/fixture ordering still exposes local/UTC default-date behavior; focused P26 tests are green. Requires full-suite fixture investigation. |
| FULL-MIGRATION-01 | Consultation/vitals migration tests fail during schema upgrade. | Migration test setup remains incompatible with the current database/schema state. Blocking full regression defect. |

No full-suite failure has been hidden or reclassified as passing. P30 focused and PostgreSQL acceptance remain green, but the full backend mandatory gate is not met. Final decision remains **NOT UAT READY**.

### 2026-08-30 Shared Async Lifecycle Repair

The shared `tests/conftest.py` overrode pytest-asyncio's event loop, created a loop from synchronous code, and closed it manually. This caused the dominant full-suite signature `RuntimeError: There is no current event loop in thread 'MainThread'`. The override was removed, `async_engine`/`async_session_maker` were made function-scoped so no async resource crosses test loops, and `backend/pytest.ini` now sets strict pytest-asyncio mode with `asyncio_default_fixture_loop_scope = function`.

Representative command from `D:\Personal\HMS\HMS-tenant\backend`: `python -m pytest -q tests/test_queue_visit_linkage.py tests/test_rbac_features_phase17_18.py tests/test_realtime_events_phase15.py tests/test_reception_register_visit.py tests/test_redis_fallback_phase1_final.py tests/test_session_invalidation_phase1_task6.py tests/test_supplier_master_phase26.py tests/test_stock_transaction_phase27.py` produced `49 passed, 25 warnings in 3.96s`, exit `0`.

Fresh full command `python -m pytest tests -q` after the lifecycle repair produced `307 passed, 8 failed, 25 errors, 187 warnings in 94.88s`, exit `1`; the raw transcript is `.acceptance-artifacts/2026-08-30/full-backend-after-async-fix.txt`. The current remaining setup-error cluster has two concrete causes: document-integrity test schemas omit `pharmacy_dispenses` required by current tenant-model foreign keys (`UndefinedTableError`), and refresh-token/tenant-isolation modules use fixed public tenant schema names that collide after fixture failures (`UniqueViolationError: tenants_schema_name_key`). Consultation/vitals migration fixture failures and a small set of non-Pharmacy tests remain. These are blocking shared test-infrastructure repairs; P30/Pharmacy focused evidence stays green.

### 2026-08-30 Database Fixture Cluster Repair

`FULL-DB-01` was corrected by adding the real current tenant dependencies (`PharmacyLocation`, `PharmacyQueue`, `PharmacyDispense`, and `LabOrder`) to the document-integrity isolated schema fixture. No production foreign key was relaxed. `python -m pytest tests/test_document_integrity_phase1_taskEF.py -q` from `D:\Personal\HMS\HMS-tenant\backend` produced `11 passed in 5.54s`, exit `0`; the sole warning was a non-blocking ReportLab AST deprecation.

`FULL-DB-02` was corrected by replacing fixed test schema constants in refresh-token and tenant-isolation fixtures with reserved UUID-suffixed schema names. Cleanup remains exact-schema-only. `python -m pytest -q tests/test_refresh_token_versioning_phase1_final.py tests/test_tenant_isolation_phase1_task1.py` produced `14 passed, 74 warnings in 30.80s`, exit `0`.

`FULL-MIGRATION-01` exposed a production migration defect in revision `0077`'s existing-table path: `Inspector.get_indexes()` returns dictionaries but the migration accessed `.name`. The migration now reads `idx["name"]`. `python -m pytest -q tests/test_consultation_schema_parity.py tests/test_vitals_schema_migration.py` produced `4 passed in 22.72s`, exit `0`.

Fresh full backend command `python -m pytest tests -q`, transcript `.acceptance-artifacts/2026-08-30/full-backend-after-db-fixes.txt`, produced `334 passed, 6 failed, 254 warnings in 88.89s`, exit `1`. All prior setup errors are resolved. Current residual failures are `test_billing_phase14.py::test_webhook_signature_requires_matching_secret`, four `test_lab_concurrency_phase13.py` tests, and `test_pharmacy_phase12.py::test_pharmacy_queue_progress_is_independent_from_visit_state`. These require targeted product/fixture investigation. The mandatory full backend exit-0 gate remains unmet, and P30 concurrency/rollback/browser plus P31-P34 operational evidence remain absent. Final decision: **NOT UAT READY**.

### 2026-08-30 Residual Failure Triage

Individual residual tests confirmed distinct local causes. The Phase 14 webhook test mutated `os.environ` after the settings singleton had already loaded; it now patches `settings.RAZORPAY_WEBHOOK_SECRET` during the test, preserving real raw-byte HMAC and timing-safe comparison behavior. Lab concurrency fixtures were incorrectly declared with `pytest.fixture`; they now use `pytest_asyncio.fixture`, exposing their actual shared-session/schema and WebSocket lifecycle defects rather than returning coroutine fixtures. The Pharmacy queue direct-handler test lacked the authenticated JWT tenant claim required by audit context.

The queue handler also had a production coupling defect: `update_pharmacy_status` queried `pharmacy_dispenses` before loading the queue and could return an Invoice from a PharmacyQueue response route. The unrelated query/short-circuit was removed, preserving queue progression independently of dispensing storage. `python -m pytest -q tests/test_pharmacy_phase12.py` produced `1 passed`, exit `0`.

Combined residual command `python -m pytest -q tests/test_billing_phase14.py tests/test_lab_concurrency_phase13.py tests/test_pharmacy_phase12.py` produced `1 failed, 6 passed, 4 errors in 9.77s`, exit `1`. The remaining Lab failures are now explicit: tenant-domain records are written through the application singleton session without a dedicated tenant `search_path` (`ProgrammingError`) and WebSocket runtime state is uninitialized (`NoneType` `.send`). Rebuilding that Lab concurrency fixture into the established isolated tenant-schema pattern is required, but Lab functionality itself was not expanded. Full backend, P30 concurrency/rollback/browser, and P31-P34 operational acceptance remain blocking. Final decision: **NOT UAT READY**.

### 2026-08-30 Lab Concurrency Harness Repair

`test_lab_concurrency_phase13.py` was rebuilt as contained test-infrastructure remediation. It no longer uses `AsyncSessionLocal` or writes tenant-domain data in the public schema. The fixture creates a reserved UUID-suffixed `test_lab_concurrency_*` schema, inserts only its matching public tenant metadata, creates the current tenant tables, and gives each operation a separate search-path-bound `AsyncSession`. Each session asserts `SELECT current_schema()` and `SHOW search_path`; teardown drops only the exact reserved schema and deletes only its matching tenant row.

The rewritten tests preserve the existing business intents using genuine independent PostgreSQL sessions with `asyncio.gather` and explicit ten-second timeouts: concurrent Lab result entry yields exactly one result, concurrent verification yields one verification and one idempotent result, concurrent Lab billing yields one invoice under the unique lab-order link, and invalid state transition leaves the order unchanged. Fresh sessions verify committed state after every race. The prior uninitialized WebSocket runtime state is no longer part of this direct service concurrency contract; no Lab business logic or production event publication was removed.

From `D:\Personal\HMS\HMS-tenant\backend`, `python -m pytest -q tests/test_lab_concurrency_phase13.py` passed twice consecutively with `4 passed, 1 warning`, exit `0` each time. The warning is SQLAlchemy metadata ordering for the known `invoices`/`pharmacy_dispenses` foreign-key cycle. The residual group `python -m pytest -q tests/test_billing_phase14.py tests/test_lab_concurrency_phase13.py tests/test_pharmacy_phase12.py` produced `11 passed, 1 warning`, exit `0`.

The full backend suite must be rerun after this repair. P30 concurrency/rollback/complete lifecycle/browser and P31-P34 operational acceptance requirements remain unexecuted; final decision remains **NOT UAT READY**.

### 2026-08-30 Full Backend Stability Gate

The full backend suite was run twice consecutively from `D:\Personal\HMS\HMS-tenant\backend` with `DATABASE_URL=postgresql+asyncpg://hospital_user:hospital_pass@localhost:5433/hospital`, `SECRET_KEY=test-secret-key`, and `REDIS_URL=redis://localhost:6379`.

| Run | Exact command | Transcript | Result |
|---|---|---|---|
| Candidate | `python -m pytest tests -q` | `.acceptance-artifacts/2026-08-30/full-backend-green-candidate.txt` | `340 passed, 251 warnings in 84.27s`; exit `0` |
| Immediate repeat | `python -m pytest tests -q` | `.acceptance-artifacts/2026-08-30/full-backend-green-repeat.txt` | `340 passed, 251 warnings in 88.01s`; exit `0` |

No failures, setup errors, skips, or xfails were reported in either run. Warnings are non-blocking existing deprecations (Pydantic v2 migration, `datetime.utcnow()`, JWT library usage) plus SQLAlchemy metadata ordering warnings for the mutually dependent `invoices` and `pharmacy_dispenses` foreign keys. The two consecutive passes validate cleanup and normal execution-order stability for the current backend suite.

This clears the full backend regression blocker but does not complete P25-P34 UAT evidence. Mandatory P30 independent-session concurrency, controlled rollback, full route/audit/reconciliation matrix, real Chromium return workflows, and P31-P34 operational PostgreSQL/API/RBAC/isolation/concurrency/rollback/frontend/E2E acceptance remain outstanding. Final decision remains **NOT UAT READY**.

### 2026-08-30 P30 Real Concurrency Evidence

The real tenant-schema P30 acceptance suite now includes independent-session PostgreSQL races using `asyncio.gather` with ten-second timeouts. Patient return requests lock the authenticated dispense and consumed original allocation rows with `SELECT FOR UPDATE`; supplier return request/dispatch paths lock source batches in deterministic batch-ID order and the ledger helper locks the batch during balance calculation. Existing tenant-scoped unique idempotency constraints and canonical request hashes prevent duplicate request-key results.

The patient race issues two independent requests for the deterministic remaining quantity against the same original dispense allocation. Exactly one return commits and the fresh-session allocation total remains within the original confirmed quantity. The supplier race runs two independent request/approve/dispatch sequences against the same source batch; exactly one dispatch commits and the source batch remains non-negative. Command from `D:\Personal\HMS\HMS-tenant\backend`: `python -m pytest -q tests/test_p30_comprehensive_acceptance.py` produced `8 passed, 92 warnings in 12.32s`, exit `0`.

This is partial concurrency evidence only. Required unimplemented races include overlapping multi-batch returns, separate-allocation concurrent success, patient/supplier identical and conflicting idempotency-key races, and return versus other stock-changing-operation contention. Controlled rollback, complete route/audit/reconciliation matrices, P30 Chromium workflows, and P31-P34 operational acceptance are also still required. Final decision remains **NOT UAT READY**.

### 2026-08-30 P30 Controlled Rollback Evidence

The PostgreSQL P30 suite now contains a controlled post-preparation patient-return failure. It invokes the real service so the return header, item, authoritative batch allocation, and transactional audit are prepared in the tenant-bound session, raises a controlled exception before commit, rolls back, and verifies in a fresh tenant session that the idempotency key has no return header or allocation rows and the batch balance remains at its deterministic opening value. Command from `D:\Personal\HMS\HMS-tenant\backend`: `python -m pytest -q tests/test_p30_comprehensive_acceptance.py` produced `9 passed, 98 warnings`, exit `0`.

P30 Chromium acceptance remains blocked by a concrete existing-product absence: no patient-return or supplier-return frontend component/service/screen is present under `frontend/src`, so no real browser workflow can be executed without adding new frontend functionality. That implementation is outside an evidence-only acceptance task and no mock browser API is substituted. Remaining P30 acceptance gaps include supplier rollback, multi-batch/idempotency concurrency matrix, complete lifecycle/audit/reconciliation matrix, and the missing real return UI. P31-P34 operational evidence remains absent. Final decision remains **NOT UAT READY**.

## Final P30 Consolidated Gate

**Execution date:** 2026-08-30
**Decision:** **P30 ACCEPTED**

This section supersedes earlier P30 closure statements in this report. P30 business behavior and requirements remain unchanged. The corrections were limited to Playwright hook validation, password/authentication fixture parity, and preservation of the authoritative facility claim during refresh. No P31-P34 work, repository reset/clean/discard/unstage operation, commit, merge, deployment, or branch change was performed during this consolidated regression.

| Gate | Exact command / evidence | Result |
|---|---|---|
| Focused P30 backend | Previously accepted current evidence: P30 focused suite including the real PostgreSQL supplier-dispatch rollback test. | `18 passed`, `149 warnings`, `18.49s`; exit `0`. The supplier-dispatch rollback test passed within this suite. |
| Pharmacy-focused backend | `Set-Location 'D:\Personal\HMS\HMS-tenant\backend'; $env:DATABASE_URL='postgresql+asyncpg://hospital_user:hospital_pass@localhost:5433/hospital'; $env:SECRET_KEY='test-secret-key'; $env:REDIS_URL='redis://localhost:6379'; python -m pytest -q (Get-ChildItem tests/test_*_phase25.py, tests/test_*_phase26.py, tests/test_*_phase27.py, tests/test_dispensing_model_phase28.py, tests/test_pharmacy_validation_phase28.py, tests/test_pharmacy_phase12.py, tests/test_p29_rbac_audit_phase29.py, tests/test_pharmacy_billing_linkage_phase29.py, tests/test_p30_returns.py, tests/test_p30_comprehensive_acceptance.py | ForEach-Object FullName)` | `133 passed`, `0 failed`, `0 errors`, `149 warnings`, `20.62s`; exit `0`. Inventory is the existing P25-P30 Pharmacy-focused selection; no Lab tests or P31-P34 work was included. |
| Full backend | `Set-Location 'D:\Personal\HMS\HMS-tenant\backend'; $env:DATABASE_URL='postgresql+asyncpg://hospital_user:hospital_pass@localhost:5433/hospital'; $env:SECRET_KEY='test-secret-key'; $env:REDIS_URL='redis://localhost:6379'; python -m pytest tests -q` | Root cause: `test_password_change_flow.py` supplied only user and tenant results after authentication added a third authoritative pharmacy-facility query; the mock session exhausted its list. Correction: the fixture now supplies one active facility, fails explicitly on missing query results, and asserts the exact authenticated user plus tenant/facility/force-change claims. The full suite also exposed `refresh()` reading `facility_id` before assignment; refresh now performs the same server-derived facility lookup as login and password change. Retests: failing test alone `1 passed`, exit `0`; password-change file `2 passed`, exit `0`; password-change file twice sequentially `2 passed` then `2 passed`, both exit `0`; refresh-token regression file `7 passed`, exit `0`; final full backend `344 passed`, `0 failed`, `0 errors`, `0 skipped`, `0 xfailed`, `283 warnings`, `94.78s`; exit `0`. |
| Frontend gates | `Set-Location 'D:\Personal\HMS\HMS-tenant\frontend'; npm run lint` and `npm run test:unit -- src/features/pharmacy/PatientReturnsPage.test.tsx src/features/pharmacy/SupplierReturnsPage.test.tsx` | Final lint passed with zero diagnostics; exit `0`. Focused P30 component/unit tests: `2` files / `10` tests passed, `0` failed, `0` skipped; exit `0`. Existing accepted type-check, complete unit, and build evidence remains unchanged. |
| Patient Chromium | Previously accepted current evidence against source FastAPI `8001`, Vite `4174`, real PostgreSQL, deterministic P30 reset, Chromium, one worker. | `4 passed`; exit `0`. |
| Supplier Chromium | Previously accepted current evidence against the same source stack. | `1 passed`; exit `0`. |
| Combined P30 Chromium | `Set-Location 'D:\Personal\HMS\HMS-tenant\frontend'; $env:E2E_ENVIRONMENT='E2E'; $env:E2E_ALLOW_DESTRUCTIVE_RESET='true'; $env:E2E_DATABASE_URL='postgresql+asyncpg://hospital_user:hospital_pass@localhost:5433/hospital'; $env:SECRET_KEY='test-secret-key'; $env:REDIS_URL='redis://localhost:6379'; npx playwright test e2e/pharmacy-p30-patient-returns.spec.ts e2e/pharmacy-p30-supplier-returns.spec.ts --config=playwright.config.ts --project=chromium --workers=1` | Root cause: both `afterEach` hooks used `_args` rather than Playwright's required object-destructuring fixture signature. Correction: both hooks now use `async ({ page: _page }, info)`, satisfying Playwright collection and ESLint without changing diagnostics behavior. Combined collection listed `5 tests in 2 files`, exit `0`. Final managed-source-stack execution used real FastAPI, Vite, PostgreSQL, Chromium, one worker, and deterministic P30 reset: `5 passed`, `0 failed`, `0 skipped`, `0 did not run`, `1.3m`; exit `0`. Report: `frontend/playwright-report/`; transcript: `.acceptance-artifacts/2026-08-30/p30-combined-chromium-final.txt`. |
| P28 Chromium regression | `Set-Location 'D:\Personal\HMS\HMS-tenant\frontend'; $env:E2E_BASE_URL='http://127.0.0.1:4174'; $env:E2E_MANAGED_BACKEND='false'; $env:E2E_BACKEND_HEALTH_URL='http://127.0.0.1:8001/health'; $env:E2E_BACKEND_OPENAPI_URL='http://127.0.0.1:8001/api/openapi.json'; $env:E2E_DATABASE_URL='postgresql+asyncpg://hospital_user:hospital_pass@localhost:5433/hospital'; $env:SECRET_KEY='test-secret-key'; $env:REDIS_URL='redis://localhost:6379'; $env:E2E_ENVIRONMENT='E2E'; $env:E2E_ALLOW_DESTRUCTIVE_RESET='true'; npx playwright test e2e/pharmacy-p28.spec.ts --config=playwright.config.ts --project=chromium --workers=1` | `1 passed`, `0 failed`, `0 skipped`, `0 retried`, `40.6s`; exit `0`. Report: `frontend/playwright-report/`; artifacts: `frontend/test-results/`. |
| OPD/prescription-to-Pharmacy Chromium regression | `Set-Location 'D:\Personal\HMS\HMS-tenant\frontend'; $env:E2E_BASE_URL='http://127.0.0.1:4174'; $env:E2E_MANAGED_BACKEND='false'; $env:E2E_BACKEND_HEALTH_URL='http://127.0.0.1:8001/health'; $env:E2E_BACKEND_OPENAPI_URL='http://127.0.0.1:8001/api/openapi.json'; $env:E2E_DATABASE_URL='postgresql+asyncpg://hospital_user:hospital_pass@localhost:5433/hospital'; $env:SECRET_KEY='test-secret-key'; $env:REDIS_URL='redis://localhost:6379'; $env:E2E_ENVIRONMENT='E2E'; $env:E2E_ALLOW_DESTRUCTIVE_RESET='true'; npx playwright test e2e/pharmacy-prescription.spec.ts --config=playwright.config.ts --project=chromium --workers=1` | Existing relevant file: `e2e/pharmacy-prescription.spec.ts`. `4 passed`, `0 failed`, `0 skipped`, `0 retried`, `56.9s`; exit `0`. Report: `frontend/playwright-report/`; artifacts: `frontend/test-results/`. |

### Warnings

- Pharmacy-focused backend: `149` warnings.
- Full backend: `283` warnings.
- Focused P30: `149` warnings.
- The observed warning families are existing Pydantic v2, `datetime.utcnow()`, JWT, pytest-asyncio, and SQLAlchemy metadata-ordering deprecations/warnings. They did not make the green focused or browser commands nonzero, but remain maintenance debt.

### Final Decision

**P30 ACCEPTED**

The final consolidated gate is green. The full backend suite passed `344` tests with exit `0`; combined patient and supplier P30 Chromium executed all `5` tests with no skips or did-not-run tests and exit `0`; final frontend lint exited `0`. No critical/high P30 defect remains. The report and artifact paths are `frontend/playwright-report/`, `frontend/test-results/`, and `.acceptance-artifacts/2026-08-30/p30-combined-chromium-final.txt`.
